Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000731945 | SCV000617405 | uncertain significance | not provided | 2017-07-11 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the RELN gene. The D1499H variant has been reported previously in an individual with autism spectrum disorder; however, no further information was provided (Matsunami et al., 2014). The D1499H variant is observed in 17/66738 (0.03%) alleles from individuals of European background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The D1499H variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV000684890 | SCV000812351 | likely benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2024-10-10 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000731945 | SCV000859818 | uncertain significance | not provided | 2018-02-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764663 | SCV000895793 | uncertain significance | Epilepsy, familial temporal lobe, 1; Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001158968 | SCV001320644 | uncertain significance | Norman-Roberts syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
New York Genome Center | RCV000731945 | SCV001441445 | uncertain significance | not provided | 2021-11-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000731945 | SCV004155685 | uncertain significance | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing |